Statistics from Altmetric.com
Q Are routine rotavirus vaccinations (3 times/infant) cost effective in the US?
Clinical impact ratings GP/FP/Primary care ★★★★★★☆ Paediatrics (general) ★★★★★★☆ Public health ★★★★★★☆
cost effectiveness study using a probabilistic (Monte Carlo) model.
nationwide in the US.
a hypothetical cohort of 4 010 000 children monitored from 0 to 59 months of age.
routine vaccinations for infants at 2, 4, and 6 months of age with a pentavalent human bovine reassortant rotavirus vaccine (PVR) (RotaTeq; Merck, Whitehouse Station, NJ, USA) or no vaccinations.
deaths, hospital admissions, emergency department visits, office visits, and episodes with home care; and the cost effectiveness ratio per case (any disease) averted, per serious case (hospital admission, …
For correspondence: Dr M A Widdowson, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Source of funding: Centers for Disease Control and Prevention.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.